Back to Search

MICHAEL JAMESON, M.D

M.D

Nephrology Physician

NPI: 1306895347IndividualAccepts Medicare

Specialties, Licenses & Credentials

Nephrology PhysicianPrimary

Internal Medicine — Nephrology

Code: 207RN0300X

HO492(TX)

CMS Specialties

PrimaryNEPHROLOGY

Education

UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON

Class of 1985

Research & Publications (20)

Transient retinal effects of 5,6-dimethylxanthenone-4-acetic acid (DMXAA, ASA404), an antitumor vascular-disrupting agent in phase I clinical trials.
PMID 19387077·Invest Ophthalmol Vis Sci·2009
3-trial
Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.
PMID 19409645·Lung Cancer·2009
3-trial
Some reflections on H1N1 influenza.
PMID 19650300·Md Med·2009
8-other
Pandemic flu update.
PMID 18491813·Md Med·2008
6-review
Community-associated MRSA.
PMID 18491810·Md Med·2008
6-review
Population pharmacokinetic-pharmacodynamic model of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid in cancer patients.
PMID 18381951·Clin Cancer Res·2008
3-trial
Emerging infectious diseases. Introduction.
PMID 18491809·Md Med·2008
8-other
Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.
PMID 19078952·Br J Cancer·2008
3-trial
First-year trends in self-reported general health predict survival in patients with head and neck cancer.
PMID 18794441·Arch Otolaryngol Head Neck Surg·2008
8-other
Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial.
PMID 17021822·Cancer Chemother Pharmacol·2007
3-trial
Confronting the challenges of medicine.
PMID 18773564·Md Med·2007
8-other
Early experience with novel immunomodulators for cancer treatment.
PMID 17714025·Expert Opin Investig Drugs·2007
6-review
Open-label escitalopram treatment for pathological skin picking.
PMID 17690595·Int Clin Psychopharmacol·2007
2-rct
Chemotherapy prescription patterns in colon cancer: a patterns-of-care survey in New Zealand.
PMID 17653254·N Z Med J·2007
8-other
General health measures and long-term survival in patients with head and neck cancer.
PMID 17520761·Arch Otolaryngol Head Neck Surg·2007
8-other
Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
PMID 16306230·Mol Pharmacol·2006
7-preclinical
Current posttraumatic stress disorder and history of trauma in trichotillomania.
PMID 16897695·J Clin Psychol·2006
8-other
5,6-Dimethylxanthenone-4-acetic acid in the treatment of refractory tumors: a phase I safety study of a vascular disrupting agent.
PMID 16551862·Clin Cancer Res·2006
3-trial
Some reflections on health care reform.
PMID 17112123·Md Med·2006
8-other
A practical office-based perspective on patient safety.
PMID 16454432·Md Med·2005
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1132 S. BOWEN RD.
ARLINGTON, TX 76013

Location

Practice Location

1132 S. BOWEN RD., ARLINGTON, TX
(817) 265-9700

Quick Facts

NPI
1306895347
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
41
Publications
20

Are you this provider?

Claim Your Profile